mog peptide 35-55 mouse rat acetate Peptide - modern-peptides mouse Understanding MOG Peptide 35-55 in Mouse and Rat Models

mob-peptides-coupon-code MOG peptide 35-55 mouse rat acetate is a specific fragment of the Myelin Oligodendrocyte Glycoprotein (MOG) that plays a crucial role in neurological research, particularly in the study of demyelinating diseases.Myelin Oligodendrocyte Glycoprotein Peptide (35-55), Rat, ... This particular peptide sequence, comprising amino acids 35 through 55 of MOG, is widely utilized in animal models to induce and investigate conditions similar to multiple sclerosis (MS) in humans.

Myelin Oligodendrocyte Glycoprotein (MOG) itself is a vital component of the central nervous system (CNS) myelin sheath. It is primarily found in the CNS, where it contributes to the structure and function of the myelin, a fatty layer that insulates nerve fibers and allows for rapid transmission of electrical signals. The MOG peptide (35-55) is a well-characterized epitope derived from this protein.Biochem/physiol Actions. Induces experimental autoimmune encephalomyelitis in rodents; a single injection of thispeptideproduces a relapsing-remitting ...

In the context of research, the MOG peptide 35-55 is extensively used to trigger experimental autoimmune encephalomyelitis (EAE) in laboratory animalsMyelin Oligodendrocyte Glycoprotein (35-55) rat MOG .... EAE is an animal model that closely mimics the pathology and clinical manifestations of human demyelinating diseases, such as multiple sclerosisMyelin Oligodendrocyte Glycoprotein Peptide Fragment 35 .... When administered to susceptible species like mouse and rat, this peptide elicits an autoimmune response targeting the myelin sheath. This response leads to inflammation, demyelination, and neurological deficits, providing researchers with a valuable tool to study disease mechanisms and test potential therapeutic interventions.

The form in which this MOG peptide is often supplied is as an acetate salt. For instance, MOG peptide (35-55), mouse, rat acetate is a common designation.Myelin Oligodendrocyte Glycoprotein Peptide Fragment 35 ... The acetate form is frequently chosen for its stability and solubility, facilitating its use in experimental setups. Variations may also include the trifluoroacetate salt, such as MOG (35-55) (TFA) (149635-73-4 free base), which is also used for inducing EAE282T7657L). Myelin Oligodendrocyte Glycoprotein (MOG)peptide(35-55) ,mouse,rat acetateis a MOG peptide (35-55) derivative. MOG peptide (35-55) is a part of .... The CAS number 149635-73-4 is often associated with this specific peptideMOG (35-55) mouse, rat [149635-73-4].

Researchers often work with specific quantities, such as 1 mg of the MOG peptide (35-55).Myelin Oligodendrocyte Glycoprotein (MOG) 35-55 (mouse ... The purity of these peptides is critical for experimental reproducibility, with specifications often requiring purity of ≥97% (HPLC) and a single impurity of ≤1.0%. The molecular weight of the MOG peptide 35-55 is approximately 25822016年5月6日—To induce i.v. tolerance 200 μg/mouseofMOG35–55 peptidewas i.v. ...RatIgG2k; APCRatIgG2a,RatIgG1; PerCP-Cy5.5RatIgG2b. Cells ....00 g/molBuy high-qualityMog 35 55 Peptideonline. Research-gradeMog 35 55 Peptideavailable for metabolic research studies..

The immunogenicity of the MOG 35-55 peptide is well-establishedMyelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat .... Upon injection, it stimulates T cell responses in mouse and rat models, leading to the infiltration of immune cells into the CNS and subsequent damage to myelinMOG (35-55) mouse, rat (Myelin Oligodendrocyte .... Studies have investigated various aspects of this immune response, including the characterization of T cell responses and the identification of specific epitopes. For example, research has explored how citrullinated human and murine MOG35–55 display distinct biochemical behaviors.

The experimental induction of EAE using MOG 35-55 can result in varied outcomes depending on the strain of the animal and the experimental protocolMyelin Oligodendrocyte GlycoproteinPeptide(35-55),Rat,Mouse. For cellular and molecular biology applications. Available in 1 mg.. Some studies describe a relapsing-remitting form of EAE, while others may observe more chronic or progressive disease. The timing of disease onset and severity can also be influenced by factors such as the dose of the MOG 35-55 peptide and the adjuvant used in the immunization2016年5月6日—To induce i.v. tolerance 200 μg/mouseofMOG35–55 peptidewas i.v. ...RatIgG2k; APCRatIgG2a,RatIgG1; PerCP-Cy5.5RatIgG2b. Cells .... For instance, a single injection of this peptide can produce a relapsing-remitting EAE.

Beyond its role in inducing EAE, the MOG 35-55 peptide is also used in various immunological assays, such as T cell stimulation assays, to assess antigen-specific T cell reactivity. The Mouse Myelin-oligodendrocyte glycoprotein Peptide is a high-quality epitope peptide for the stimulation of antigen-specific T cellsMyelin Oligodendrocyte Glycoprotein (MOG)peptide(35-55) ,mouse,rat acetateis a MOG peptide (35-55) derivative. MOG peptide (35-55) is a part of myelin ....

In summary, MOG peptide 35-55 mouse rat acetate is a vital research reagent, indispensable for modeling demyelinating diseases like MS in animal studiesMyelin Oligodendrocyte Glycoprotein Peptide (35-55), Rat, .... Its specific sequence, its role as an antigen, and its ability to induce EAE in mouse and rat models make it a cornerstone in neuroimmunology research. The availability of this MOG peptide in various forms, including acetate and trifluoroacetate salts, and with defined purity levels, ensures its reliable application in advancing our understanding of neurological disorders.